Human KLF14 adenoviral particles

The Krüppel-like factor 14 (KLF14) gene encodes a member of the Krüppel-like family of transcription factors that play key roles in regulating processes such as cell proliferation, differentiation, and metabolism. KLF14 is particularly noteworthy for its involvement in metabolic pathways and has been identified as a major trans-regulator of gene expression in adipose tissue. As a transcription factor, KLF14 regulates the expression of target genes by binding to specific DNA sequences, often exerting either repressive or activating effects depending on the cellular context. Its expression is enriched in adipose tissue, but can also be detected in other tissues. KLF14 is a promising target for therapeutic intervention due to its potential role in obesity, insulin resistance, and cardiovascular disease.

Human KLF14 Adenoviral Particles are genetically engineered viral vectors designed to deliver the KLF14 gene to mammalian cells for research purposes. These particles are based on adenovirus serotype 5 (Ad5), a widely used vector system known for its high transduction efficiency in both dividing and non-dividing cells. KLF14 adenoviral particles are a valuable tool for studying gene function, allowing researchers to overexpress KLF14 in vitro or in vivo to study its role in metabolic regulation, cell differentiation, and disease mechanisms. For example, they can be used to explore the effects of KLF14 on adipocyte biology or the insulin signaling pathway. In addition, these particles are used in preclinical studies to evaluate the potential of KLF14 in the treatment of metabolic disorders.